There’s a new plot twist in the takeover battle between French pharmaceutical giant Sanofi-Aventis and U.S. drugmaker Genzyme. A regulatory filing made by Genzyme on Thursday claims Sanofi may be willing to go much higher than …
Global pharmaceutical sales are expected to grow by 5% to 7% in 2011, thanks to robust growth in emerging markets, especially China, as well as new innovative treatments, and despite patent expirations and budget pressures in t…
The problem of faulty foreclosure documents isn’t limited to GMAC: A JPMorgan Chase employee has testified that she was one of eight managers who combined to sign some 18,000 documents a month without the personal knowledge of …
Looking for stocks that could move fast? Hilary Kramer, editor of GameChangerStocks.com, recommends taking a look at two lesser-known pharmaceuticals, Shire and Medco Health Systems, that she says will benefit greatly in the near term.
Continue reading Under the Radar: Two Ways to Profit from Growth in Pharmaceuticals
Under the Radar: Two Ways to Profit from Growth in Pharmaceuticals originally appeared on DailyFinance on Wed, 22 Sep 2010 15:30:00.
Filed Under: Investing, JP Morgan Chase, Johnson & Johnson, Pfizer, Merck
While a new report from Goldman Sachs says health care is in a state of flux that most of the sector’s companies haven’t adjusted to yet, it also pinpoints four that have plenty of cash that could be put to good use for investo…